Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK ® (vanzacaftor/tezacaftor/ivacaftor) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results